Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha

Blood. 1998 Oct 1;92(7):2260-8.

Abstract

Hypoxia results in adaptive changes in the transcription of a range of genes including erythropoietin. An important mediator is hypoxia-inducible factor-1 (HIF-1), a DNA binding complex shown to contain at least two basic helix-loop-helix PAS-domain (bHLH-PAS) proteins, HIF-1alpha and aryl hydrocarbon nuclear receptor translocator (ARNT). In response to hypoxia, HIF-1alpha is activated and accumulates rapidly in the cell. Endothelial PAS domain protein 1 (EPAS-1) is a recently identified bHLH-PAS protein with 48% identity to HIF-1alpha, raising the question of its role in responses to hypoxia. We developed specific antibodies and studied expression and regulation of EPAS-1 mRNA and protein across a range of human cell lines. EPAS-1 was widely expressed, and strongly induced by hypoxia at the level of protein but not mRNA. Comparison of the effect of a range of activating and inhibitory stimuli showed striking similarities in the EPAS-1 and HIF-1alpha responses. Although major differences were observed in the abundance of EPAS-1 and HIF-1alpha in different cell types, differences in the inducible response were subtle with EPAS-1 protein being slightly more evident in normoxic and mildly hypoxic cells. Functional studies in a mutant cell line (Ka13) expressing neither HIF-1alpha nor EPAS-1 confirmed that both proteins interact with hypoxically responsive targets, but suggest target specificity with greater EPAS-1 transactivation (relative to HIF-1alpha transactivation) of the VEGF promoter than the LDH-A promoter.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aryl Hydrocarbon Receptor Nuclear Translocator
  • Basic Helix-Loop-Helix Transcription Factors
  • CHO Cells
  • COS Cells
  • Cell Hypoxia / physiology*
  • Cell Line
  • Cobalt / pharmacology
  • Cricetinae
  • Cricetulus
  • DNA-Binding Proteins / biosynthesis*
  • DNA-Binding Proteins / genetics
  • Deferoxamine / pharmacology
  • Endothelial Growth Factors / genetics
  • Gene Expression Regulation*
  • HeLa Cells / drug effects
  • HeLa Cells / metabolism
  • Humans
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Iron Chelating Agents / pharmacology
  • L-Lactate Dehydrogenase / genetics
  • Lymphokines / genetics
  • Mice
  • Mice, Inbred BALB C
  • Nuclear Proteins / biosynthesis*
  • Nuclear Proteins / genetics
  • Onium Compounds / pharmacology
  • Promoter Regions, Genetic
  • RNA, Messenger / biosynthesis
  • Receptors, Aryl Hydrocarbon*
  • Recombinant Fusion Proteins / biosynthesis
  • Trans-Activators / biosynthesis*
  • Trans-Activators / genetics
  • Transcription Factors / metabolism
  • Transcriptional Activation
  • Transfection
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • ARNT protein, human
  • Arnt protein, mouse
  • Basic Helix-Loop-Helix Transcription Factors
  • DNA-Binding Proteins
  • Endothelial Growth Factors
  • HIF1A protein, human
  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Iron Chelating Agents
  • Lymphokines
  • Nuclear Proteins
  • Onium Compounds
  • RNA, Messenger
  • Receptors, Aryl Hydrocarbon
  • Recombinant Fusion Proteins
  • Trans-Activators
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Aryl Hydrocarbon Receptor Nuclear Translocator
  • endothelial PAS domain-containing protein 1
  • Cobalt
  • diphenyleneiodonium
  • L-Lactate Dehydrogenase
  • cobaltous chloride
  • Deferoxamine